Search For "sirol"
TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB
Updated : 3 years, 8 months ago IST
Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized
Read More
First patient enrolled in Erectile Dysfunction prospective randomized stud
Updated : 3 years, 8 months ago IST
Geneva [Switzerland], September 10 (ANI/PRNewswire): An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon.
Read More
First US patient enrolled in SELUTION SLR IDE Peripheral Study
Updated : 3 years, 9 months ago IST
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Read More
MedAlliance SELUTION SLR receives second FDA IDE approval
Updated : 3 years, 9 months ago IST
Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial
Read More
LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK ta
Updated : 3 years, 10 months ago IST
Munster, (Germany), July 30 (ANI/PRNewswire): LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug-Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSea
Read More
First patient enrolled in SELUTION SLR IDE BTK Study
Updated : 3 years, 12 months ago IST
Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval.
Read More
Much awaited, much needed: TRANSFORM II Randomized Controlled Trial by Fon
Updated : 4 years, 4 months ago IST
Milano (Italy) [India], January 28 (ANI/PR Newswire): FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Nativ
Read More
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly
Updated : 4 years, 4 months ago IST
Singapore, January 25 (ANI/PRNewswire): Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomized
Read More
MedAlliance announces completion of enrollment in Japanese SELUTION SLR
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], September 23 (ANI/PRNewswire): MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD).
Read More
ABILITY Diabetes Global enrolls thousandth patient: A cardinal milestone a
Updated : 4 years, 8 months ago IST
Tampa (Florida) [India], September 9 (ANI/PRNewswire): ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index patient enrolment on
Read More
MedAlliance announces first patient enrolled in the 3,300 Patient Landmark
Updated : 4 years, 9 months ago IST
Geneva [Switzerland], September 1 (ANI/PRNewswire): MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], ver
Read More
MedAlliance announces enrollment of first patient in erectile dysfunction
Updated : 4 years, 9 months ago IST
Nyon [Switzerland], August 19 (ANI/PRNewswire): MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB].
Read More